Marcie A. Goldstein
Lawyers
Filters
Xencor, Inc. Follow-On Offering
Davis Polk advised the sole book-running manager in connection with the $126.5 million public offering of common stock of Xencor, Inc. The common stock is listed on the NASDAQ Global Market…
Kinsale Capital Group, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $106.3 million follow-on offering of 3,864,000 shares of common stock of…
BeiGene, Ltd. Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $200 million public offering by BeiGene, Ltd. of 6,250,000 American Depositary Shares, of…
Bunge Finance Europe €200 Million Senior Notes Reopening
Davis Polk advised the joint book-running managers in connection with an SEC-registered reopening of €200 million aggregate principal amount of 1.850% senior notes due 2023 by Bunge Finance…
Summit Materials $367 Million Secondary Offering
Davis Polk advised the sole underwriter in connection with the approximately $367 million secondary offering of 16,614,949 shares of common stock of Summit Materials, Inc. by certain…
Hilton $1.3 Billion Secondary Offering
Davis Polk advised the underwriter in connection with the $1.3 billion secondary offering of 55,000,000 shares of common stock of Hilton Worldwide Holdings Inc. by certain selling…
Century Communities, Inc. $50 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount of …
Quantenna Communications, Inc. IPO
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $107 million initial public offering by Quantenna Communications, Inc. of 6,700,000…
Theravance Biopharma, Inc. Concurrent Ordinary Shares and Convertible Senior Notes Offerings
Davis Polk advised the joint book-running managers in connection with a $100.1 million SEC-registered offering of 3,850,000 ordinary shares of Theravance Biopharma, Inc. The ordinary…
iRhythm Technologies, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the initial public offering by iRhythm Technologies, Inc. iRhythm sold 7,238,235 shares…